ScinoPharm Taiwan, Ltd. (TPE:1789)
Taiwan · Delayed Price · Currency is TWD 19.10
+0.15 (0.79%)
Oct 8, 2026, 1:30 PM CST
ScinoPharm Taiwan Market Cap
ScinoPharm Taiwan has a market cap or net worth of 15.1 billion as of October 9, 2026. It is the 15,244th most valuable company in the world and the 548th biggest in Taiwan. Its market cap has decreased by 4.26% in one year.
Market Cap
15.10B
Enterprise Value
12.48B
Revenue
3.07B
Global Rank
Country Rank
#548 Taiwan
PE Ratio
400.32
ChartMarket Cap Chart
Since October 29, 2010, ScinoPharm Taiwan's market cap has decreased from 30.44B to 15.10B, a decrease of -50.38%. That is a compound annual growth rate of -4.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 15.10B | 14.03% |
| Dec 31, 2025 | 13.24B | -24.04% |
| Dec 31, 2024 | 17.44B | -16.48% |
| Dec 29, 2023 | 20.88B | 3.73% |
| Dec 30, 2022 | 20.12B | 3.25% |
| Dec 30, 2021 | 19.49B | -14.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Center Laboratories | 24.60B |
| Handa Pharmaceuticals | 20.32B |
| TTY Biopharm Company | 19.97B |
| Synmosa Biopharma | 15.80B |
| YungShin Global Holding | 15.29B |
| Grape King Bio | 12.58B |
| Foresee Pharmaceuticals | 12.45B |
| Standard Chemical & Pharmaceutical | 10.02B |